Welcome to our dedicated page for abrdn Healthcare Opportunities news (Ticker: THQ), a resource for investors and traders seeking the latest updates and insights on abrdn Healthcare Opportunities stock.
abrdn Healthcare Opportunities Fund (THQ) is a closed-end investment fund focused on global healthcare companies, offering investors exposure to biotechnology, pharmaceuticals, and medical technology sectors. This news hub provides timely updates on THQ's strategic developments and market activities.
Access official press releases, earnings reports, and sector analysis in one centralized location. Investors will find updates on portfolio adjustments, distribution announcements, and regulatory filings that impact the fund's performance.
Key coverage includes quarterly financial results, partnership announcements, healthcare market trends affecting holdings, and capital allocation decisions. All content is verified through primary sources to ensure accuracy and compliance with financial reporting standards.
Bookmark this page for streamlined tracking of THQ's developments in the dynamic healthcare investment landscape. Check regularly for updates that may influence long-term strategy and income distribution policies.
Tekla Healthcare Opportunities Fund has renewed its share repurchase program, allowing the purchase of up to 12% of its outstanding common shares for one year, ending July 14, 2022. The renewal aims to enhance shareholder value and reduce the discount between the market price and net asset value (NAV) per share. The repurchases will be at the discretion of Tekla Capital Management LLC, the Fund's adviser. Although intended to increase NAV, there is no guarantee that share repurchases will bolster the Fund’s market price.
On March 9, 2021, Tekla Healthcare Opportunities Fund announced a monthly cash distribution of $0.1125 per share, with a record date of March 19, 2021 and payment set for March 31, 2021. The Fund will be ex-distribution on March 18, 2021. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will automatically reinvest cash distributions into shares. The Fund, which trades under the symbol THQ, focuses on investing in the healthcare sector and is advised by Tekla Capital Management LLC.
On February 9, 2021, Tekla Healthcare Opportunities Fund declared a cash distribution of $0.1125 per share. The record date for this distribution is February 19, 2021, with a payable date of February 26, 2021. Shares will trade ex-distribution on February 18, 2021. This closed-end fund focuses on investments in the healthcare sector, managed by Tekla Capital Management LLC from Boston. Participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have their distributions automatically reinvested.
On January 11, 2021, Tekla Healthcare Opportunities Fund (NYSE: THQ) announced a monthly cash distribution of $0.1125 per share. The record date for this distribution is January 21, 2021, with the payable date set for January 29, 2021. The Fund will trade ex-distribution on January 20, 2021. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have cash distributions automatically reinvested in shares. Tekla Capital Management LLC serves as the Fund’s Investment Adviser.
On December 8, 2020, Tekla Healthcare Opportunities Fund (NYSE: THQ) announced a monthly cash distribution of $0.1125 per share. The record date for this distribution is December 18, 2020, with the payable date set for December 31, 2020. The Fund will trade ex-distribution on December 17, 2020. Participants in the Fund's Dividend Reinvestment and Stock Purchase Plan (DRIP) will have cash distributions reinvested automatically. Tekla Capital Management LLC serves as Investment Adviser to the Fund.
Tekla Healthcare Opportunities Fund (THQ) announced a distribution of $0.1125 per share on November 30, 2020. This distribution comprises 6% from net investment income, 8% from long-term capital gains, and 86% as return of capital. Cumulatively, THQ has distributed $0.2250 this fiscal year, with -3.82% total return at NAV through October 31, 2020. The fund's investment performance is subject to future market conditions and realized gains or losses on securities.
On November 9, 2020, Tekla Healthcare Opportunities Fund declared a monthly cash distribution of $0.1125 per share. The record date is November 20, 2020, with a payable date of November 30, 2020. The Fund will be ex-distribution on November 19, 2020. Participants in the Fund's Dividend Reinvestment and Stock Purchase Plan will have distributions automatically reinvested.
Tekla Healthcare Opportunities Fund (NYSE: THQ) invests in the healthcare sector and is advised by Tekla Capital Management LLC. Shares are available for purchase on the NYSE.
The Tekla Healthcare Opportunities Fund (NYSE: THQ) announced a monthly distribution of $0.1125 per share on October 30, 2020. This payout is primarily derived from net investment income and a return of capital, which may fluctuate based on future gains and losses. The current fund's portfolio includes net unrealized appreciation of approximately $60.7 million, against net realized losses. For the fiscal year, the annualized distribution rate is 6.66% based on NAV, with a cumulative total return at NAV of 16.30% year-to-date.
On October 9, 2020, Tekla Healthcare Opportunities Fund declared a monthly cash distribution of $0.1125 per share. The record date for this distribution is October 20, 2020, and it will be payable on October 30, 2020. The Fund's shares will trade ex-distribution on October 19, 2020. Participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan (DRIP) will have their cash distributions automatically reinvested. The Fund, based in Boston, primarily invests in the healthcare sector, and its shares trade on the NYSE under the symbol THQ.
Tekla Healthcare Opportunities Fund (THQ) announced a monthly distribution of $0.1125 per share on September 30, 2020. This amount is derived from net realized short-term and long-term capital gains, with total cumulative distributions for the fiscal year-to-date reaching $1.3500. The Fund's net unrealized appreciation of portfolio securities stands at $43,548,569. It is noted that distributions may include a return of capital, which does not reflect the Fund’s investment performance. The annualized current distribution rate is 6.42%.
FAQ
What is the current stock price of abrdn Healthcare Opportunities (THQ)?
What is the market cap of abrdn Healthcare Opportunities (THQ)?
